Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

NCT04102371 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 9041

Last updated 2026-03-05

No results posted yet for this study

Summary

The objectives of this multicenter pragmatic clinical trial are to compare the effectiveness and relative safety of balanced fluid resuscitation versus 0.9% "normal" saline in children with septic shock, including whether balanced fluid resuscitation can reduce progression of kidney injury.

Conditions

  • Shock
  • Septic

Interventions

DRUG

Lactated Ringer

LR is a sterile, nonpyrogenic "balanced" solution used for fluid and electrolyte replenishment via intravenous or intraosseous administration. Each 100 mL of LR contains 600 mg sodium chloride (NaCl), 310 mg of sodium lactate (C3H5NaO3), 30 mg of potassium chloride (KCl), and 20 mg of calcium chloride (CaCl2 · 2H20) with an approximate potential of hydrogen (pH) of 6.5 (6.0 to 7.5).

DRUG

Normal Saline

Normal saline solution is an "unbalanced" crystalloid solution containing 154 mEq/L of sodium and 154 milliequivalent (mEq/L) of chloride.

DRUG

Plasma-lyte

PL is a sterile, nonpyrogenic isotonic solution in a single dose container for intravenous administration. Each 100 mL contains 526 mg of Sodium Chloride, USP (NaCl); 502 mg of Sodium Gluconate (C6H11NaO7); 368 mg of Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O); 37 mg of Potassium Chloride, USP (KCl); and 30 mg of Magnesium Chloride, USP (MgCl2•6H2O). It contains no antimicrobial agents. The pH is adjusted with sodium hydroxide. The pH is 7.4 (6.5 to 8.0).

Sponsors & Collaborators

  • Boston Children's Hospital

    collaborator OTHER
  • Children's Healthcare of Atlanta

    collaborator OTHER
  • Children's Hospital Colorado

    collaborator OTHER
  • Children's Hospital Los Angeles

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • Children's Hospital and Health System Foundation, Wisconsin

    collaborator OTHER
  • Children's Medical Center Dallas

    collaborator OTHER
  • Children's National Research Institute

    collaborator OTHER
  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER
  • Hasbro Children's Hospital

    collaborator OTHER
  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER
  • Nationwide Children's Hospital

    collaborator OTHER
  • Primary Children's Hospital

    collaborator OTHER
  • Seattle Children's Hospital

    collaborator OTHER
  • St. Louis Children's Hospital

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • University of California, Davis

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • Kidz First Hospital Middlemore

    collaborator UNKNOWN
  • Gold Coast Hospital and Health Service

    collaborator OTHER_GOV
  • Queensland Children's Hospital

    collaborator OTHER_GOV
  • Westmead Children's Hospital

    collaborator UNKNOWN
  • Sydney Children's Hospitals Network

    collaborator OTHER
  • Perth Children's Hospital

    collaborator UNKNOWN
  • Starship Children's Hospital

    collaborator UNKNOWN
  • Monash Children's Hospital

    collaborator UNKNOWN
  • Women's and Children's Hospital, Australia

    collaborator OTHER_GOV
  • Royal Children's Hospital

    collaborator OTHER
  • Royal Darwin Hospital

    collaborator UNKNOWN
  • Virginia Commonwealth University

    collaborator OTHER
  • Alberta Children's Hospital

    collaborator OTHER
  • British Columbia Children's Hospital

    collaborator OTHER
  • Centre Hospitalier Univeritaire Sainte Justine

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire de Quebec

    collaborator UNKNOWN
  • Children's Hospital of Eastern Ontario

    collaborator OTHER
  • The Hospital for Sick Children

    collaborator OTHER
  • IWK Health Centre

    collaborator OTHER
  • Jim Pattison Children's Hospital

    collaborator UNKNOWN
  • Kingston Health Sciences Centre

    collaborator OTHER
  • London Health Sciences Centre

    collaborator OTHER
  • McMaster Children's Hospital

    collaborator OTHER
  • Stollery Children's Hospital

    collaborator OTHER
  • The Children's Hospital of Winnipeg

    collaborator OTHER
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • Pennsylvania Department of Health

    collaborator OTHER_GOV
  • Townsville University Hospital

    collaborator OTHER
  • Hospital nacional de niños Costa Rica

    collaborator UNKNOWN
  • Morgan Stanley Children's Hospital

    collaborator OTHER
  • Children's Hospital of Philadelphia

    lead OTHER

Principal Investigators

  • Fran Balamuth, MD PhD MSCE · Attending Physician, Emergency Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-25
Primary Completion
2025-12-01
Completion
2026-01-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04102371 on ClinicalTrials.gov